- Experience standing up omnichannel engagement and next-best-action capabilities in a regulated pharma commercial environment.
- Familiarity with Patient Services / hub operations and specialty data flows.
- Experience with identity resolution and privacy-by-design architectures in a regulated industry.
- Deep familiarity with the Veeva ecosystem (CRM, Vault, Network) and its data integration patterns.
- Experience with Snowflake Cortex, Streamlit or equivalent governed, enterprise-grade LLM/AI enablement.
- Background in real time personalization engineering, including A/B testing infrastructure and journey orchestration platforms.
- Experience with multi touch attribution modeling and marketing mix analytics data products.
- Cloud certification (AWS Solutions Architect or equivalent); working knowledge of AWS core services (S3, Lambda).
- Prior experience in rare disease, specialty pharma, or biotech commercial operations.
- Track record of recruiting and developing engineering talent from adjacent industries (financial services, technology, consumer digital).
About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.
Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others.
Before applying, please review Alnylam's Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment.